Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets

 v2.3.0.11
Balance Sheets (USD $)
Jun. 30, 2011
Sep. 30, 2010
CURRENT ASSETS    
Cash $ 878,538 $ 422,414
Prepaid expenses 31,854 34,889
Grant receivable   65,122
Security deposits   85,025
Total Current Assets 910,392 607,450
EQUIPMENT, net 20,416 24,168
OTHER ASSETS    
Patent costs, net 721,681 780,407
TOTAL ASSETS 1,652,489 1,412,025
CURRENT LIABILITIES    
Accounts payable and accrued expenses 325,055 332,772
Accrued salaries   5,453
Short-term notes payable   17,486
Convertible debentures   51,115
Total Current Liabilities 325,055 406,826
LONG-TERM LIABILITIES    
Stock warrant derivative liability 4,861,699 1,387,656
Total Long-term Liabilities 4,861,699 1,387,656
TOTAL LIABILITIES 5,186,754 1,794,482
STOCKHOLDERS' EQUITY (DEFICIT)    
Preferred stock, Series B; 15,000,000 shares authorized, at $0.0001 par value, 5,583,336 and 5,583,336 shares issued and outstanding, respectively 558 558
Common stock; 180,000,000 shares authorized, at $0.0001 par value, 39,702,580 and 35,452,580 shares issued and outstanding, respectively 3,970 3,545
Additional paid-in capital 22,178,436 21,587,433
Accumulated deficit (21,628,748) (21,628,748)
Deficit accumulated during the development stage (4,088,481) (345,245)
Total Stockholders' Equity (Deficit) (3,534,265) (382,457)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) $ 1,652,489 $ 1,412,025